Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Onset of alcohol or substance use disorders following treatment for adolescent depression.

Curry J, Silva S, Rohde P, Ginsburg G, Kennard B, Kratochvil C, Simons A, Kirchner J, May D, Mayes T, Feeny N, Albano AM, Lavanier S, Reinecke M, Jacobs R, Becker-Weidman E, Weller E, Emslie G, Walkup J, Kastelic E, Burns B, Wells K, March J.

J Consult Clin Psychol. 2012 Apr;80(2):299-312. doi: 10.1037/a0026929. Epub 2012 Jan 16.

2.

The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.

March J, Silva S, Vitiello B; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1393-403.

PMID:
17135984
3.

Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.

Kratochvil CJ, May DE, Silva SG, Madaan V, Puumala SE, Curry JF, Walkup J, Kepley H, Vitiello B, March JS.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):519-27. doi: 10.1089/cap.2008.0143.

4.

Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.

Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, Salloum IM.

Addict Behav. 2011 Aug;36(8):843-8. doi: 10.1016/j.addbeh.2011.03.016. Epub 2011 Apr 9.

5.

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11.

PMID:
17135985
6.

Acute time to response in the Treatment for Adolescents with Depression Study (TADS).

Kratochvil C, Emslie G, Silva S, McNulty S, Walkup J, Curry J, Reinecke M, Vitiello B, Rohde P, Feeny N, Casat C, Pathak S, Weller E, May D, Mayes T, Robins M, March J; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1412-8.

PMID:
17135986
7.

Treatment for Adolescents with Depression Study (TADS): safety results.

Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S, Weller E, Waslick B, Casat C, Walkup J, Pathak S, Rohde P, Posner K, March J; Columbia Suicidality Classification Group; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1440-55.

8.

A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.

Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK.

Arch Pediatr Adolesc Med. 2007 Nov;161(11):1026-34.

PMID:
17984403
9.

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

Curry J, Rohde P, Simons A, Silva S, Vitiello B, Kratochvil C, Reinecke M, Feeny N, Wells K, Pathak S, Weller E, Rosenberg D, Kennard B, Robins M, Ginsburg G, March J; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39.

PMID:
17135988
10.

Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.

Cornelius JR, Bukstein OG, Wood DS, Kirisci L, Douaihy A, Clark DB.

Addict Behav. 2009 Oct;34(10):905-9. doi: 10.1016/j.addbeh.2009.03.008. Epub 2009 Mar 12.

11.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
12.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
13.

Mental health service use among adolescents following participation in a randomized clinical trial for depression.

Brenner SL, Burns BJ, Curry JF, Silva SG, Kratochvil CJ, Domino ME.

J Clin Child Adolesc Psychol. 2015;44(4):551-8. doi: 10.1080/15374416.2014.881291. Epub 2014 Mar 24.

14.

Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).

Lewis CC, Simons AD, Nguyen LJ, Murakami JL, Reid MW, Silva SG, March JS.

J Am Acad Child Adolesc Psychiatry. 2010 Feb;49(2):132-40.

PMID:
20215935
15.

Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.

Davis LL, Rush JA, Wisniewski SR, Rice K, Cassano P, Jewell ME, Biggs MM, Shores-Wilson K, Balasubramani GK, Husain MM, Quitkin FM, McGrath PJ.

Compr Psychiatry. 2005 Mar-Apr;46(2):81-9.

PMID:
15723023
16.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Sch├╝tz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
17.

Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.

Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS.

Arch Gen Psychiatry. 2008 Apr;65(4):447-55. doi: 10.1001/archpsyc.65.4.447.

18.
19.

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.

Treatment for Adolescents With Depression Study (TADS) Team, March J, Silva S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Vitiello B, Severe J, Riedal K, Goldman M, Feeny N, Findling R, Stull S, Baab S, Weller EB, Robbins M, Weller RA, Jessani N, Waslick B, Sweeney M, Dublin R, Walkup J, Ginsburg G, Kastelic E, Koo H, Kratochvil C, May D, LaGrone R, Vaughan B, Albano AM, Hirsch GS, Podniesinki E, Chu A, Reincecke M, Leventhal B, Rogers G, Jacobs R, Pathak S, Wells J, Lavanier SA, Danielyan A, Rohde P, Simons A, Grimm J, Frank S, Emslie G, Kennard B, Hughes C, Mayes TL, Rosenberg D, Benazon N, Butkus M, Bartoi M.

Am J Psychiatry. 2009 Oct;166(10):1141-9. doi: 10.1176/appi.ajp.2009.08111620. Epub 2009 Sep 1.

PMID:
19723787
20.

Major depression and treatment response in adolescents with ADHD and substance use disorder.

Warden D, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Tamm L, Trello-Rishel K, Winhusen T.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):214-9. doi: 10.1016/j.drugalcdep.2011.08.001. Epub 2011 Aug 31.

Supplemental Content

Support Center